Dilon Devices Announced Today that a U.S. Food and Drug Administration (FDA) Advisory Panel Voted (10 to 1) in favor of Dune’s MarginProbe® System
[vc_row][vc_column][vc_column_text]FDA Advisory Panel Votes in Favor of Dilon Devices MarginProbe® System Gaithersburg, MD, June 22, 2012 –…
Leading Experts Discussed Clinical Results and Cost Effectiveness of Intraoperative Detection of Cancer on the Tissue Margin During Lumpectomy for Breast Cancer
[vc_row][vc_column][vc_column_text]Leading experts discussed clinical results and cost effectiveness of intra-operative detection of cancer on the tissue margin…
Dune’s MarginProbe® Approved by Israel’s Largest HMO
[vc_row][vc_column][vc_column_text]4 Million Covered Lives Provided Access to MarginProbe Caesarea, Israel, March 12, 2012. Dilon announced today that…
Analysis of the Impact of Intraoperative Margin Assessment with Adjunctive Use of MarginProbe® versus Standard of Care on Tissue Volume Removed
[vc_row][vc_column][vc_column_text]View the study by clicking here.[/vc_column_text][/vc_column][/vc_row]
Use of MarginProbe® in DCIS Patients Presented at San Antonio Breast Cancer Symposium
[vc_row][vc_column][vc_column_text] MarginProbe use reduces re-excision surgeries in patients with diffuse disease Framingham, MA, December 8, 2011- An…
MarginProbe® Pivotal Study Presented at San Antonio Breast Cancer Symposium
[vc_row][vc_column][vc_column_text] MarginProbe use reduces re-excision surgeries while conserving tissue Framingham, MA, December 7, 2011- Data from the…
Study of Dilon’s MarginProbe® Published in Major European Journal
[vc_row][vc_column][vc_column_text] Significant Reduction in Re-Excision Rate Documented by German Researchers Framingham, MA, November 30, 2011- A clinical…
Dilon’s MarginProbe® Obtains Procedure Code for Reimbursement in Germany
[vc_row][vc_column][vc_column_text] New Code Represents a Major Step in Securing Widespread Reimbursement Framingham, MA, November 28, 2011- The…
Dilon Announces Appointment of Roger Blanchette as Chief Financial Officer
[vc_row][vc_column][vc_column_text] Management Adds Experienced Financial Executive Framingham, MA, November 23, 2011. Dilon Devices announced today the appointment…
Dilon’s Chief Executive to Present at Upcoming Piper Jaffray Healthcare Conference
[vc_row][vc_column][vc_column_text]Framingham, MA, November 23, 2011-Dilon Devices, Inc. today announced that its CEO, Dan Levangie, will participate in…
Dilon’s MarginProbe® the Focus of Major Symposium at the 2011 German Forum for Operative Gynecology Meeting in Berlin
[vc_row][vc_column][vc_column_text] Dan Levangie Appointed as CEO ahead of FDA Approval and US Launch Framingham, MA (PRWEB) October…
FDA Formally Accepts Dilon’s MarginProbe® System Pre-Market Approval (PMA) Application and Grants Expedited Review Status
[vc_row][vc_column][vc_column_text]FRAMINGHAM, MA, May 16, 2011 – Dilon Devices, Inc. today announced that the U.S. Food and Drug…
How can we help?
Before you commit to a particular
course of treatment, talk to us.